Resultados de la búsqueda 781-790 of 13686 for 香港搜尋引擎入口 🔍 www.7.hk.cn

  1. Hematología - Ensayos clínicos

    This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor that has spread to other places in the ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Additional components will also included genomic and molecular analysis of tumor tissue as we search for novel targets for therapy. A Study To Compare ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Additional components will also included genomic and molecular analysis of tumor tissue as we search for novel targets for therapy. A Study To Compare ...

  4. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the impact of pulse electromagnetic field (PEMF) therapy using the Bioboosti device (Biomobie Regenerative ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to compare the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden.

  6. Hematología - Ensayos clínicos

    The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma, (RR ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery ...

  8. Intoxicación: primeros auxilios - Mayo Clinic

    Accessed March 7, 2022. Swallowed a button battery? Battery in the nose or ear? National Capital Poison Center. https://www.poison.org/battery. Accessed ...

  9. Oncología (médica) - Ensayos clínicos

    Usual treatment after a complete response may include observation or high dose chemotherapy followed by an autologous stem cell transplant, however, it is not ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...